These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12858498)

  • 1. [Oestrogel--a transdermal and convenient method of hormone replacement therapy].
    Krumov G
    Akush Ginekol (Sofiia); 2003; 42 Suppl 1():17-20. PubMed ID: 12858498
    [No Abstract]   [Full Text] [Related]  

  • 2. Transdermal estradiol. A potentially improved method of hormone replacement.
    Judd HL
    J Reprod Med; 1994 May; 39(5):343-52. PubMed ID: 8064701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A
    Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal estradiol reduces F2alpha-isoprostane levels in postmenopausal women.
    Hermenegildo C; Oviedo PJ; Laguna A; García-Pérez MA; Tarín JJ; Cano A
    Menopause; 2008; 15(4 Pt 1):714-7. PubMed ID: 18340278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone replacement therapy and insulin metabolism: effects of route of administration and implications for heart disease and diabetes risk.
    Godsland IF; Stevenson JC
    Br J Clin Pract Suppl; 1996 Sep; 86():1-5. PubMed ID: 8995002
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estrogen replacement therapy with oestrogel].
    Pekhlivanov B
    Akush Ginekol (Sofiia); 2003; 42(4):38-41. PubMed ID: 14577367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mineral bone density in adolescents with hypogonadism: results of two hormonal replacement therapies].
    Sodini F; Bertelloni S; Baroncelli GI; Basiloni V; Tacchini S; Saggese G
    Minerva Pediatr; 2001 Oct; 53(5):471-2. PubMed ID: 11668274
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of transdermal oestradiol (Estraderm TTS) in hypertensive postmenopausal women.
    Foidart JM
    Br J Clin Pract Suppl; 1996 Sep; 86():14-6. PubMed ID: 8995005
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal versus oral administration of estrogen in the management of lumbar spine osteopenia in an adolescent with anorexia nervosa.
    Harel Z; Riggs S
    J Adolesc Health; 1997 Sep; 21(3):179-82. PubMed ID: 9283939
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmenopausal hormone-replacement therapy, plasma lipoprotein[a], and risk for coronary heart disease.
    Gotto AM
    J Lab Clin Med; 1994 Jun; 123(6):800-3. PubMed ID: 8201254
    [No Abstract]   [Full Text] [Related]  

  • 17. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R
    Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in C-reactive protein levels induced by different application forms of estrogen replacement therapy].
    Fait T; Vrablík M; Kostírová M; Trnková B
    Cas Lek Cesk; 2006; 145(7):571-4; discussion 574. PubMed ID: 16921788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
    Fait T; Vrablik M; Zizka Z; Kostirova M
    Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.